i(17)(q10)
Epidemiology and
Etiology:
·
By far the most frequent neoplasia-associated
isochromosome overall
·
CML
·
AML
·
M>F (2.3:1)
·
Elderly (almost exclusively), median 65 y.
·
Almost always de novo rather than after chemotherapy
·
MDS
·
MPN
·
Lymphoid disorders
·
Formed by an intrachromosomal
recombination event
Common sites:
·
Gross features:
·
AML:
·
Splenomegaly maybe
·
Hepatomegaly maybe
Histologic
features:
·
AML:
·
All FAB subtypes except M6
·
Prominent basophilia and eosinophilia
·
Dysplastic megakaryocytes
Immunophenotype:
Marker: |
Sensitivity: |
Specificity: |
|
|
|
Molecular features:
·
Actually it is a dicentric chromosome
·
Clustered breakpoints in 17p11
·
TP53 gene deleted
·
But accompanying TP53 mutations have not been particularly
associated
·
?TP53 is not the target of this lesion
·
AML:
·
Sole change in 40%
·
Common additional abnormalities:
·
+8, -7, -5, +13, +11, +19, -12
·
Rarely a secondary change to characteristic AML-associated
translocations and inversions
·
CML:
·
Common secondary change to t(9;22)
·
May appear to be the sole change in the presence of a cryptic
t(9;22)
·
MDS and MPN:
·
Isolated usually
Other features:
·
MDS and MPN:
·
Associated with rapid progression to AML
·
AML:
·
Poor response to chemotherapy
·
Short survival
References:
·
Heim S, Mitelman F. Cancer Cytogenetics. 3rd ed. Wiley-Blackwell;
2009.